Segall Bryant & Hamill’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-455,384
Closed -$3.16M 586
2024
Q2
$3.16M Buy
+455,384
New +$3.2M 0.06% 340
2014
Q2
Sell
-11,500
Closed -$70K 568
2014
Q1
$70K Sell
11,500
-9,900
-46% -$72.8K ﹤0.01% 569
2013
Q4
$187K Hold
21,400
﹤0.01% 567
2013
Q3
$89K Buy
+21,400
New +$118K ﹤0.01% 565

Other funds holding MDXG

Segall Bryant & Hamill's MDXG Position: Q3 2024 in Review

Segall Bryant & Hamill sold out of MiMedx Group (MDXG) in Q3 2024, closing a stake of 455,384 shares — an estimated $3.16M sold.

Segall Bryant & Hamill first reported a position in MDXG in Q3 2013 and held it in 4 quarters. The position peaked at $3.16M in Q2 2024. 194 funds tracked by Wall St. Rank hold MDXG as of Q3 2024.

  • Segall Bryant & Hamill reported no remaining MiMedx Group position as of Q3 2024 after selling out during the quarter.
  • Segall Bryant & Hamill sold 455,384 MiMedx Group shares in Q3 2024, an estimated $3.16M.
  • Segall Bryant & Hamill first reported a position in MiMedx Group in Q3 2013 and held it in 4 quarters.
  • Segall Bryant & Hamill's MiMedx Group position peaked at $3.16M in Q2 2024.
  • 194 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2024.

Based on Segall Bryant & Hamill's 13F filing for Q3 2024, filed 8 Nov 2024.